The previous study indicated gene mutation of SH2D1A, which was thought to act as a negative regulator of immune cell activation, leaded to X-linked lymphoproliferative syndrome (XLP) [39], in contrast, SHP-2 acted in positive manner to transduce signals from receptor protein tyrosine kinases [14]. This evidence concerns the gene PTPN11 and X-linked lymphoproliferative disease.